Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01664741 · ClinicalTrials.gov registry record · Phase 4
Nicotine Dependence, Withdrawal and Replacement Therapy Assessed by PET Imaging
A Phase 4 study of Nicotine Dependence, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 4
- Development phase
- 127
- Enrollment target
- 1
- Study location
NCT01664741 is a Phase 4 study of Nicotine Dependence that has completed, run by Johns Hopkins University. The registered enrollment target is 127 participants, below the 185-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (31% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01664741, a Phase 4 study of Nicotine Dependence, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 127 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed research will provide significant new gender-specific information of scientific and clinical relevance on the function of the mu-opioid system in nicotine dependence and therapeutic effectiveness of nicotine replacement therapy (NRT). The studies will help to explain the differences in the prevalence of smoking in men and women, sex-specific differences in nicotine craving and withdrawal as well as the poorer therapeutic response to NRT. This work may pave the way to the design of improved pharmacotherapies that can more effectively target the endogenous opioid system in the treatment of nicotine dependence.
Conditions Studied
Interventions
- DRUG placebo
- DRUG Nicotine patch - transdermal
Study Locations (1)
Maryland
- Johns Hopkins University School of Medicine - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 127 participants |
| Start Date | 2012-04 |
| Est. Completion | 2018-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01664741
The ClinicalTrials.gov registry entry for NCT01664741 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 127 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 185-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (31% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Nicotine Dependence appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT01664741 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT01664741 about?
NCT01664741 is a clinical study titled "Nicotine Dependence, Withdrawal and Replacement Therapy Assessed by PET Imaging". The proposed research will provide significant new gender-specific information of scientific and clinical relevance on the function of the mu-opioid system in nicotine dependence and therapeutic effectiveness of nicotine replacement therapy (NRT). The studies will help to explain the differences in ...
What is the current status of trial NCT01664741?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 127 participants. The study started on 2012-04. Estimated completion is 2018-12.
What conditions does trial NCT01664741 study?
This clinical trial studies the following conditions: Nicotine Dependence.
What interventions are being tested in trial NCT01664741?
The interventions under investigation include: placebo (DRUG), Nicotine patch - transdermal (DRUG).
Who is sponsoring clinical trial NCT01664741?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01664741 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nicotine Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Beta-Adrenergic Modulation of Drug Cue Reactivity
RECRUITING · Phase 4
-
E-cigarette Cessation in Adults Who Co-use Cannabis
RECRUITING · Phase 4
-
Methadone-Maintained Smokers Switching to E-Cigarettes
ACTIVE NOT RECRUITING · Phase 4
-
Identifying Treatments to Motivate Smokers to Quit
COMPLETED · Phase 4
-
Progesterone and Brain Imaging Study
COMPLETED · Phase 4
-
Bupropion for ADHD in Adolescents With Substance Use Disorder
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.